Regulated markets sales (78% of sales) grew 29% YoY/ 16% QoQ on strong growth in US (over 20% YoY) and steady growth in Australia (high single digit). However, Emerging markets sales (22% of sales) declined 39% YoY/ 38% QoQ due to API supply chain disruption, pricing issues in the ARV portfolio